ABCB7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.8536000229451E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.99629995762041E-09 |
Normal-vs-Stage2 |
1.848130E-02 |
Normal-vs-Stage3 |
7.776700E-04 |
Normal-vs-Stage4 |
1.187880E-02 |
Stage1-vs-Stage2 |
4.252600E-01 |
Stage1-vs-Stage3 |
7.811400E-01 |
Stage1-vs-Stage4 |
7.455400E-01 |
Stage2-vs-Stage3 |
6.463000E-01 |
Stage2-vs-Stage4 |
4.411000E-01 |
Stage3-vs-Stage4 |
6.466000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.16679996167812E-09 |
Normal-vs-AfricanAmerican |
2.235200E-04 |
Normal-vs-Asian |
2.978400E-01 |
Caucasian-vs-AfricanAmerican |
4.341600E-01 |
Caucasian-vs-Asian |
5.564800E-01 |
AfricanAmerican-vs-Asian |
7.950000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.8572034455342E-11 |
Normal-vs-Female |
1.281880E-02 |
Male-vs-Female |
1.365370E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.187600E-04 |
Normal-vs-Extreme_Weight |
7.32930049984759E-10 |
Normal-vs-Obese |
1.833950E-04 |
Normal-vs-Extreme_Obese |
1.532190E-01 |
Normal_Weight-vs-Extreme_Weight |
2.362800E-01 |
Normal_Weight-vs-Obese |
7.202600E-01 |
Normal_Weight-vs-Extreme_Obese |
7.900000E-01 |
Extreme_Weight-vs-Obese |
8.340000E-02 |
Extreme_Weight-vs-Extreme_Obese |
3.261800E-01 |
Obese-vs-Extreme_Obese |
9.456000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.154600E-01 |
Normal-vs-Age(41-60Yrs) |
1.0020999996474E-07 |
Normal-vs-Age(61-80Yrs) |
4.68399996567115E-09 |
Normal-vs-Age(81-100Yrs) |
7.54080000000545E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.851790E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.230350E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.828840E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.837800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.500600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.752000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
4.33442171043907E-12 |
Normal-VS-Type2 PRCC |
7.382200E-03 |
Normal-VS-KIRP CIMP |
2.129600E-01 |
Normal-VS-Unclassified PRCC |
1.617470E-04 |
Type1 PRCC-VS-Type2 PRCC |
1.741540E-03 |
Type1 PRCC-VS-KIRP CIMP |
3.950000E-01 |
Type1 PRCC-VS-Unclassified PRCC |
2.069400E-01 |
Type2 PRCC-VS-KIRP CIMP |
7.726000E-01 |
Type2 PRCC-VS-Unclassified PRCC |
2.002600E-01 |
KIRP CIMP-VS-Unclassified PRCC |
6.321000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.2359999999999E-05 |
Normal-vs-N1 |
7.364200E-03 |
Normal-vs-N2 |
4.550400E-01 |
N0-vs-N1 |
7.656000E-01 |
N0-vs-N2 |
5.905000E-01 |
N1-vs-N2 |
7.231000E-01 |
|
|